Lo C M, Shaked A, Busuttil R W
Department of Surgery, University of California at Los Angeles.
Transplantation. 1994 Sep 15;58(5):543-7. doi: 10.1097/00007890-199409150-00003.
A retrospective study was performed to identify risk factors affecting the fate of liver allografts transplanted across the ABO barrier. Over a 5-year period, 30 patients received 31 emergency OLTs with ABO-incompatible allografts. One-year graft and patient survival rates were 37.1% and 48.4%, respectively. This group was compared with 199 ABO-compatible OLTs performed under similar emergency conditions. Significantly higher incidence of rejection, hepatic artery thrombosis, and biliary stricture were found in ABO-incompatible grafts. The graft or patient survival of patients with O blood group or fulminant hepatic failure was not affected by ABO incompatibility. In contrast, the 1-year survival of recipients with non-O blood group was only 13.3% and the 1-year survival of those undergoing retransplantation was only 27.7% after ABO-incompatible OLT. A multivariate analysis using the Cox proportional hazard model identified non-O blood group (relative risk 3.43) and retransplantation (relative risk 2.46) as the most important risk factors for patient survival after ABO-incompatible OLT. We conclude that the use of ABO-incompatible grafts is justified in emergency cases when no other donor is available, but should be proscribed in patients with non-O blood group. The value of ABO-incompatible grafts in retransplantation is questionable and requires further investigation.
进行了一项回顾性研究,以确定影响跨ABO血型屏障移植的肝移植受者预后的危险因素。在5年期间,30例患者接受了31例紧急ABO血型不相容肝移植。1年移植肝和患者生存率分别为37.1%和48.4%。将该组患者与在类似紧急情况下进行的199例ABO血型相容肝移植患者进行比较。发现ABO血型不相容移植肝的排斥反应、肝动脉血栓形成和胆管狭窄发生率显著更高。O型血患者或暴发性肝衰竭患者的移植肝或患者生存率不受ABO血型不相容的影响。相比之下,ABO血型不相容肝移植后,非O型血受者的1年生存率仅为13.3%,再次移植受者的1年生存率仅为27.7%。使用Cox比例风险模型进行的多因素分析确定,非O型血(相对风险3.43)和再次移植(相对风险2.46)是ABO血型不相容肝移植后患者生存的最重要危险因素。我们得出结论,在没有其他供体可用的紧急情况下,使用ABO血型不相容移植肝是合理的,但对于非O型血患者应予以禁止。ABO血型不相容移植肝在再次移植中的价值存在疑问,需要进一步研究。